Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Option Award |
2025-02-04 4:11 pm |
N/A 2035-02-03 |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
44,400 | $0 | 44,400 (Direct) |
View |
| 2024-12-16 Exercise |
2024-12-18 4:51 pm |
N/A 2024-12-18 |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
381 | $0 | 381 (Direct) |
View |
| 2024-12-16 Exercise |
2024-12-18 4:51 pm |
N/A N/A |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
381 | $4.41 | 381 (Direct) |
View |
| 2024-09-30 Option Award |
2024-10-02 4:13 pm |
N/A 2024-09-30 |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
29,800 | $0 | 29,800 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 06:01 am |
N/A 2034-02-01 |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
30,142 | $0 | 30,142 (Direct) |
View |
Ownership |
2023-06-07 9:53 pm |
N/A 2027-12-27 |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
0 | $0 | 90,299 (Direct) |
View |